SiNtx Technologies Inc (SINT)

[cash_cow1]

Even with a name change the company has been around for more than a decade and imo if you have not reach the point of sustainable revenue from a start up company, than NYSE need to stop issue that company unlimited a/s and r/s. The product is not generating enough suitors, buyers or interest partners to help keep the company sustain without cashing in a/s or resulting to r/s wiping out shareholders. this company is really a dead stick if it can't sustain itself with a/s, selling warrants, prefer shares or r/s after all these years. The products is not catching enough buyers or medical world professionals, patients that is interesting in its products.

Just because something sounds good and works good doesn't mean a lot of people want to buy it or use it.